CirculoGene Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 40

Employees

  • Latest Deal Type
  • Debt

  • Latest Deal Amount
  • $12.7M

  • Investors
  • 2

CirculoGene General Information

Description

Provider of molecular cancer diagnostics services intended to offer a non-invasive and cost-effective alternative for high-sensitivity monitoring across a variety of sample types. The company's services use minimal volumes of blood to provide unprecedented tumor monitoring information with an up-to-date clinical status in a complete, accurate, and timely manner, enabling physicians to detect known tumor-mutant DNA within cancer-associated genes present in diagnosed cancer patients.

Contact Information

Website
www.circulogene.com
Formerly Known As
CirculoGene Diagnostics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3125 Independence Drive
  • Suite 106
  • Birmingham, AL 35209
  • United States
+1 (855)
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Diagnostic Equipment
Vertical(s)
Oncology
Corporate Office
  • 3125 Independence Drive
  • Suite 106
  • Birmingham, AL 35209
  • United States
+1 (855)

CirculoGene Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CirculoGene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Debt - General 01-Oct-2023 $12.7M Completed Generating Revenue
8. Later Stage VC 01-May-2023 Completed Generating Revenue
7. Debt - General 01-Jan-2022 Completed Generating Revenue
6. Debt - General 22-Jan-2021 Completed Generating Revenue
5. Debt - PPP 10-Apr-2020 Completed Generating Revenue
4. Later Stage VC (Series C) 16-Sep-2019 Completed Generating Revenue
3. Grant 17-Jun-2019 Completed Generating Revenue
2. Early Stage VC (Series B) 16-Nov-2018 $3.08M $5.06M Completed Generating Revenue
1. Early Stage VC (Series A) 06-Oct-2016 $1.98M $1.98M Completed Startup
To view CirculoGene’s complete valuation and funding history, request access »

CirculoGene Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C
Series B-1
Series B
Series A-1 6,945,058 $0.000100 $0.18 $0.18 1x $0.18 26.28%
Series A 5,143,500 $0.000100 $0.18 $0.18 1x $0.18 19.47%
To view CirculoGene’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

CirculoGene Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of molecular cancer diagnostics services intended to offer a non-invasive and cost-effective alternative for hi
Laboratory Services (Healthcare)
Birmingham, AL
40 As of 2023

Austin, TX
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CirculoGene Competitors (24)

One of CirculoGene’s 24 competitors is Aspira Women's Health, a Formerly VC-backed company based in Austin, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aspira Women's Health Formerly VC-backed Austin, TX
Decipher Urologic Cancers Formerly VC-backed San Diego, CA
Inivata Formerly VC-backed Cambridge, United Kingdom
Foundation Medicine Formerly VC-backed Cambridge, MA
Genomic Expression Venture Capital-Backed Beverly, MA
You’re viewing 5 of 24 competitors. Get the full list »

CirculoGene Patents

  • 10

    Total Documents Applications and Grants

  • Total Patents Families

  • 6

    Granted

  • Pending

  • Expiring in next 12 mo

CirculoGene Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2016306688-A1 Method of preparing cell free nucleic acid molecules by in situ amplification Inactive 12-Aug-2015
AU-2021202766-A1 Method of preparing cell free nucleic acid molecules by in situ amplification Active 12-Aug-2015
US-11015213-B2 Method of preparing cell free nucleic acid molecules by in situ amplification Active 12-Aug-2015
US-20190024127-A1 Method of preparing cell free nucleic acid molecules by in situ amplification Active 12-Aug-2015
AU-2021202766-B2 Method of preparing cell free nucleic acid molecules by in situ amplification Inactive 12-Aug-2015 C12P19/34
To view CirculoGene’s complete patent history, request access »

CirculoGene Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CirculoGene Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Keiretsu Forum Angel Group Minority
United States Department of Defense Government Minority
To view CirculoGene’s complete investors history, request access »

Ready to get started?

Request a free trial

CirculoGene FAQs

  • When was CirculoGene founded?

    CirculoGene was founded in 2015.

  • Where is CirculoGene headquartered?

    CirculoGene is headquartered in Birmingham, AL.

  • What is the size of CirculoGene?

    CirculoGene has 40 total employees.

  • What industry is CirculoGene in?

    CirculoGene’s primary industry is Laboratory Services (Healthcare).

  • Is CirculoGene a private or public company?

    CirculoGene is a Private company.

  • What is CirculoGene’s current revenue?

    The current revenue for CirculoGene is .

  • How much funding has CirculoGene raised over time?

    CirculoGene has raised $38.3M.

  • Who are CirculoGene’s investors?

    Keiretsu Forum and United States Department of Defense have invested in CirculoGene.

  • Who are CirculoGene’s competitors?

    Aspira Women's Health, Decipher Urologic Cancers, Inivata, Foundation Medicine, and Genomic Expression are some of the 24 competitors of CirculoGene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »